关于我们
关于林克生物
广州林克生物科技有限公司成立于2023年，是一家致力于提供病原高通量测序整体解决方案的小微企业。
林克生物联合联合高校、疾控及第三方企业等多团队， 成功开发上市产品10余款，其中包括多种病毒基因组捕获试剂盒、辅助建库试剂盒以及测序数据分析软件等， 产品供应于全国各地疾控、高校及企业等科研单位。
林克生物坚持创新，专注病原高通量测序技术领域，潜心研究，为病原高通量测序技术服务于更多场景提供高质量的技术支持。
Linker Biotech Driven by values
Guangzhou Linker Biotech Ltd. was established in 2023 and dedicated to providing comprehensive solutions for high-throughput sequencing of pathogens.
Linker Biotech, in collaboration with multiple teams, has successfully developed and launched over 10 products, including various virus genome capture kits, auxiliary library building kits, and sequencing data analysis software. These products are supplied to research institutions such as disease control centers, universities, and enterprises across the country.
Linker Biotech adheres to innovation and focuses on the field of high-throughput sequencing technology for pathogens, dedicating itself to research and providing high-quality technical support for pathogen high-throughput sequencing technology to serve more scenarios.
Results Oriented Growth
Lorem ipsum dolor sit amet elit do, consectetur adipiscing, sed eiusmod tempor line high touch client.
Client Collaboration
Lorem ipsum dolor sit amet elit do, consectetur adipiscing, sed eiusmod tempor line high touch client.
Data-Driven Creativity
Lorem ipsum dolor sit amet elit do, consectetur adipiscing, sed eiusmod tempor line high touch client.
The team behind
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
John Marshall
Strategy
Maria Williams
Marketing
Mark Spencer
Copywriting
Helen Castillo
Public Relations
Join our team!
Feeling inspired? Join the team
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nullam nec fermentum ex. Vestibulum ante ipsum.